Navigation Links
Europe Carotenoids & Antioxidants (Nutraceuticals) Market is Expected to Reach $765.93 Million in 2018 - New Report by MicroMarket Monitor
Date:7/28/2014

(PRWEB) July 28, 2014

The Europe Carotenoids & Antioxidants Market report defines and segments the carotenoids & antioxidants market in Europe with analysis and forecast of revenue. This market is estimated to grow from $502.97million in 2012 to $765.93 million by 2018, at a CAGR of 7.3% from 2013 to 2018.

Browse through the TOC of the Europe Carotenoids & Antioxidants Market report to get an idea of the in-depth analysis provided. It also provides a glimpse of the segmentation in the market and is supported by various tables and figures.

http://www.micromarketmonitor.com/market/europe-carotenoids-antioxidants-nutraceuticals-4078442934.html

Recent awareness in the North European as well as West European region related to aging disorders has spiked the demand for nutraceuticals that incorporate carotenoids & antioxidants as their major ingredients. The market for these nutraceuticals ingredients is blooming in Europe, and is considered to be a high revenue generation market in the future. Taking into consideration the growing population combined with the rising income levels, the demand for these ingredients seems to be unending in the European region.

Early buyers will receive 10% customization on this report.

http://www.micromarketmonito
'/>"/>

Source: PRWeb
Copyright©2014 Vocus, Inc.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Europe Agricultural Adjuvants Market is Expected to Reach $657.1 million in 2018 - New Report by MicroMarket Monitor
2. Europe Bromine Market is Expected to Reach $111.6 Million in 2018 - New Report by MicroMarket Monitor
3. Europe Security and Surveillance Radar Market is Expected to Reach $1800 million in 2019 - New Report by MicroMarket Monitor
4. Europe Artificial Lift Services Market is Expected to Reach $5.4 Billion in 2018 - New Report by MicroMarket Monitor
5. Europe Gas Chromatography Reagents Market is Expected to Reach $445.5 million in 2018 - New Report by MicroMarket Monitor
6. European Liquid Chromatography Reagents Market is Expected to Reach $1581.8 Million in 2018 - New Report by MicroMarket Monitor
7. Europe Cyber Security Market is Expected to Reach $19 billion in 2019 - New Report by MicroMarket Monitor
8. Europe Alpha Olefins Market is Expected to Reach $1,958 Million in 2018 - New Report by MicroMarket Monitor
9. Is Europe putting cancer research at risk?
10. Biofeedback Federation of Europe Enters Distribution Agreement with Zukor Interactive
11. Europe Omega 3 & Structured Lipids (Nutraceuticals) Market is Expected to Reach $989.91 Million in 2018 - New Report by MicroMarket Monitor
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/30/2014)... Paramount Rx, a full-service prescription benefits manager ... help people save money through its innovative discount card ... drugs in the new health care system, the Paramount ... the relationship between consumers, businesses and the pharmacy industry. ... face today with medical costs is the rising price ...
(Date:10/30/2014)... Canada (PRWEB) October 30, 2014 Home ... area’s leading provider of non-medical, in-home senior care, is ... to increased brain health. , The study, performed by ... ages of 60 and 78 over a week-long period ... opposed to daily physical activity. By examining the structural ...
(Date:10/30/2014)... October 30, 2014 REV'D Provision Co. ... now available through a unique service called, The ... to empower the everyday athlete. The Feed has taken ... and created a system to pass that information on ... REV’D® is now available on The Feed!” says REV’D® ...
(Date:10/30/2014)... When it comes to heart disease, a new study finds ... they have symptoms that spell trouble. "The main danger ... more severe or advanced stage of heart disease, there are ... Fulbright Scholar and research fellow at the Harvard School of ... and Stroke Foundation of Canada. In the study, researchers ...
(Date:10/30/2014)... a low-carb, high-fat diet could help control epilepsy that ... A review of five studies found that a ... like bacon, eggs, heavy cream, butter, fish and green ... doesn,t improve with medication. "We need new treatments ... seizures are not stopped by medications," study co-author Dr. ...
Breaking Medicine News(10 mins):Health News:Paramount Rx Discount Card Program Provides Valuable Resources in Midst of Current Health Care Reform 2Health News:Paramount Rx Discount Card Program Provides Valuable Resources in Midst of Current Health Care Reform 3Health News:Home Care Assistance – Halton/Peel Region, a Top Provider of In-Home Care, Responds to Study Linking Exercise to Healthier Senior Brains 2Health News:Home Care Assistance – Halton/Peel Region, a Top Provider of In-Home Care, Responds to Study Linking Exercise to Healthier Senior Brains 3Health News:Nutrition Experts at TheFeed.com Get REV'D 2Health News:Nutrition Experts at TheFeed.com Get REV'D 3Health News:Women Often Ignore Signs of Heart Trouble 2Health News:High-Fat, Low-Carb Diet May Help With Tough-to-Treat Epilepsy 2Health News:High-Fat, Low-Carb Diet May Help With Tough-to-Treat Epilepsy 3
... , TUESDAY, June 29 (HealthDay News) -- Scientists report ... older women by causing certain genetic mutations. The study ... National Cancer Institute. . Previous research has indicated that ... develop colorectal cancer than those who never smoked, according to ...
... ... employers who want to provide health benefits and control costs., , ... Minneapolis, MN (PRWEB) June 29, 2010 ... largest independent insurance and employee benefits brokers in the Midwest, to offer customized defined ...
... ... Symptom Checker, a new online tool to help users evaluate their child,s symptoms. The tool ... ... if your child develops a fever, cough, vomiting, rash, sore throat or head injury? A ...
... HealthDay Reporter , TUESDAY, June 29 (HealthDay News) -- Type ... that continuously monitored their blood sugar levels had better control ... clinical trial finds. , , Researchers divided 485 people ... multiple daily insulin injections and tested their blood sugar throughout ...
... the Ohio State University Comprehensive Cancer Center-Arthur G. ... Institute (OSUCCC-James) have discovered how a substance that ... can block the proliferation of cancer cells. ... may have anticancer effects and other health benefits, ...
... powerful and highly addictive psychostimulant that is toxic to ... many parts of the United States. The National Institute ... Americans have tried methamphetamine, while more than 1.4 million ... the drug can lead to devastating medical, psychological and ...
Cached Medicine News:Health News:Bloom Health and Christensen Group Partner Together to Deliver Innovative Solution 2Health News:AAP Offers New Online Pediatric Symptom Checker on HealthyChildren.org 2Health News:Insulin Pump With Blood Sugar Sensor May Improve on Injections 2Health News:Insulin Pump With Blood Sugar Sensor May Improve on Injections 3Health News:Study shows how dietary supplement may block cancer cells 2Health News:Dental school gets $1.86 million from NIH for study of methamphetamine's effect on oral health 2
(Date:10/30/2014)... , Oct. 30, 2014 Boston Scientific ... participate in the 2014 Credit Suisse Annual Healthcare Conference ... , AZ.  Dan Brennan , executive vice ... about the company beginning at approximately 8:00 a.m. PT ... A live webcast of the presentation and question and ...
(Date:10/30/2014)... 2014  Nektar Therapeutics (Nasdaq: NKTR ) ... ended September 30, 2014 on Thursday, November 6, 2014, ... Robin , president and chief executive officer, will host ... 5:00 p.m. Eastern Time (ET)/2:00 p.m. Pacific Time (PT). ... audio-only Webcast of the conference call can be accessed ...
(Date:10/30/2014)...   Auxilium Pharmaceuticals , Inc. (NASDAQ: ... company, today announced financial results for the third ... important corporate, commercial, regulatory and clinical development updates ... very pleased with the continued momentum and strong ... portfolio this quarter, especially the XIAFLEX franchise, which ...
Breaking Medicine Technology:Boston Scientific To Participate In 2014 Credit Suisse Annual Healthcare Conference 2Nektar to Announce Financial Results for the Third Quarter 2014 on Thursday, November 6, 2014, After Close of U.S.-Based Financial Markets 2Auxilium Pharmaceuticals, Inc. Announces Third Quarter 2014 Financial Results 2Auxilium Pharmaceuticals, Inc. Announces Third Quarter 2014 Financial Results 3Auxilium Pharmaceuticals, Inc. Announces Third Quarter 2014 Financial Results 4Auxilium Pharmaceuticals, Inc. Announces Third Quarter 2014 Financial Results 5Auxilium Pharmaceuticals, Inc. Announces Third Quarter 2014 Financial Results 6Auxilium Pharmaceuticals, Inc. Announces Third Quarter 2014 Financial Results 7Auxilium Pharmaceuticals, Inc. Announces Third Quarter 2014 Financial Results 8Auxilium Pharmaceuticals, Inc. Announces Third Quarter 2014 Financial Results 9Auxilium Pharmaceuticals, Inc. Announces Third Quarter 2014 Financial Results 10Auxilium Pharmaceuticals, Inc. Announces Third Quarter 2014 Financial Results 11Auxilium Pharmaceuticals, Inc. Announces Third Quarter 2014 Financial Results 12Auxilium Pharmaceuticals, Inc. Announces Third Quarter 2014 Financial Results 13Auxilium Pharmaceuticals, Inc. Announces Third Quarter 2014 Financial Results 14Auxilium Pharmaceuticals, Inc. Announces Third Quarter 2014 Financial Results 15Auxilium Pharmaceuticals, Inc. Announces Third Quarter 2014 Financial Results 16Auxilium Pharmaceuticals, Inc. Announces Third Quarter 2014 Financial Results 17Auxilium Pharmaceuticals, Inc. Announces Third Quarter 2014 Financial Results 18Auxilium Pharmaceuticals, Inc. Announces Third Quarter 2014 Financial Results 19Auxilium Pharmaceuticals, Inc. Announces Third Quarter 2014 Financial Results 20Auxilium Pharmaceuticals, Inc. Announces Third Quarter 2014 Financial Results 21Auxilium Pharmaceuticals, Inc. Announces Third Quarter 2014 Financial Results 22
... in Combination with CRESTOR (rosuvastatin calcium) Improved LDL, HDL ... ... SEATTLE, May 31 New Phase III data showed,that in ... AstraZeneca,s CRESTOR(R) (rosuvastatin,calcium) led to greater improvements than the corresponding ...
... Annual Meeting -, SOUTH SAN FRANCISCO, ... Pharmaceuticals, Inc. (Nasdaq: PARD ), a ... safety and,efficacy data from its ongoing Phase ... docetaxel and prednisone, the standard of care ...
Cached Medicine Technology:Phase III Study of Abbott's Investigational TriLipix(TM) in Combination With AstraZeneca's CRESTOR(R) Meets Primary Endpoints on Key Lipids 2Phase III Study of Abbott's Investigational TriLipix(TM) in Combination With AstraZeneca's CRESTOR(R) Meets Primary Endpoints on Key Lipids 3Phase III Study of Abbott's Investigational TriLipix(TM) in Combination With AstraZeneca's CRESTOR(R) Meets Primary Endpoints on Key Lipids 4Poniard Announces Positive First-Line Efficacy and Safety Data From Ongoing Phase 2 Trial of Picoplatin in Patients with Metastatic Hormone Refractory Prostate Cancer 2Poniard Announces Positive First-Line Efficacy and Safety Data From Ongoing Phase 2 Trial of Picoplatin in Patients with Metastatic Hormone Refractory Prostate Cancer 3Poniard Announces Positive First-Line Efficacy and Safety Data From Ongoing Phase 2 Trial of Picoplatin in Patients with Metastatic Hormone Refractory Prostate Cancer 4
...
It is a magnifying headlight perfect for all applications and procedures where clear magnification and a natural white light increase accuracy and productivity....
It is lightweight and portable headlight option for office exam room. It offers complete comfort and portability....
Solarc surgical headlight is durable, comfortable, lightweight and delivers the bright, white light expected from a xenon system, but at a fraction of the cost....
Medicine Products: